TTM
17.2%
YoY change
+3.31pp
Trough year (2012)
-56.1%
Peak year (2019)
43.8%
Latest annual
14.4%
Net Profit Margin history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: 14.4%
Net Profit Margin change chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +3.31pp
Net Profit Margin history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | 14.4% | +3.31pp | ||
| 2024 | 11.1% | -0.12pp | ||
| 2023 | 11.2% | +5.68pp | ||
| 2022 | 5.5% | -3.24pp | ||
| 2021 | 8.7% | +9.58pp | ||
| 2020 | -0.8% | -44.61pp | ||
| 2019 | 43.8% | +26.77pp | ||
| 2018 | 17.0% | +15.86pp | ||
| 2017 | 1.1% | -2.99pp | ||
| 2016 | 4.1% | +7.33pp | ||
| 2015 | -3.2% | -1.58pp | ||
| 2014 | -1.6% | +0.08pp | ||
| 2013 | -1.7% | +54.42pp | ||
| 2012 | -56.1% | -61.90pp | ||
| 2011 | 5.8% | +19.43pp | ||
| 2010 | -13.6% | -1.13pp | ||
| 2009 | -12.5% | +12.77pp | ||
| 2008 | -25.3% | -19.37pp | ||
| 2007 | -5.9% | +39.81pp | ||
| 2006 | -45.7% | -55.73pp | ||
| 2005 | 10.0% | -8.89pp | ||
| 2004 | 18.9% | +5.30pp | ||
| 2003 | 13.6% | +0.80pp | ||
| 2002 | 12.8% | +14.80pp | ||
| 2001 | -2.0% | -16.02pp | ||
| 2000 | 14.0% | +0.95pp | ||
| 1999 | 13.1% | +24.89pp | ||
| 1998 | -11.8% | -19.28pp | ||
| 1997 | 7.4% | -3.99pp | ||
| 1996 | 11.4% | +10.71pp | ||
| 1995 | 0.7% | -17.03pp | ||
| 1994 | 17.8% | -0.58pp | ||
| 1993 | 18.3% | +0.38pp | ||
| 1992 | 18.0% | -0.22pp | ||
| 1991 | 18.2% | — |
- 202514.4%+3.31pp
- 202411.1%-0.12pp
- 202311.2%+5.68pp
- 20225.5%-3.24pp
- 20218.7%+9.58pp
- 2020-0.8%-44.61pp
- 201943.8%+26.77pp
- 201817.0%+15.86pp
- 20171.1%-2.99pp
- 20164.1%+7.33pp
- 2015-3.2%-1.58pp
- 2014-1.6%+0.08pp
- 2013-1.7%+54.42pp
- 2012-56.1%-61.90pp
- 20115.8%+19.43pp
- 2010-13.6%-1.13pp
- 2009-12.5%+12.77pp
- 2008-25.3%-19.37pp
- 2007-5.9%+39.81pp
- 2006-45.7%-55.73pp
- 200510.0%-8.89pp
- 200418.9%+5.30pp
- 200313.6%+0.80pp
- 200212.8%+14.80pp
- 2001-2.0%-16.02pp
- 200014.0%+0.95pp
- 199913.1%+24.89pp
- 1998-11.8%-19.28pp
- 19977.4%-3.99pp
- 199611.4%+10.71pp
- 19950.7%-17.03pp
- 199417.8%-0.58pp
- 199318.3%+0.38pp
- 199218.0%-0.22pp
- 199118.2%—
Net Profit Margin values are taken from Boston Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Profit Margin at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported net margin is 17.2%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Boston Scientific (BSX) net margin is 14.38% – expanded 3.3 percentage points year-over-year.
The highest annual net margin of 43.78% was reported in 2019. The lowest in the available history was -56.12% in 2012.
Boston Scientific Net Profit Margin by Year
Boston Scientific Net Profit Margin 2025: 14.4%
2025's net margin for Boston Scientific came in at 14.38%, expanded 3.3 percentage points from 2024.
Boston Scientific Net Profit Margin 2024: 11.1%
Boston Scientific posted net margin of 11.07% in 2024, contracted 0.1 percentage points from 2023.
Boston Scientific Net Profit Margin 2023: 11.2%
In 2023, Boston Scientific reported net margin of 11.19%, expanded 5.7 percentage points from 2022.
Boston Scientific Net Profit Margin 2022: 5.5%
Boston Scientific net margin in 2022 was 5.50%, contracted 3.2 percentage points from 2021.
Boston Scientific Net Profit Margin 2021: 8.7%
Boston Scientific net margin in 2021 was 8.75%.
See more financial history for Boston Scientific (BSX).
Sector peers by Net Profit Margin
Healthcare peers of Boston Scientific (BSX), ranked by their latest net margin
| 37.2% | |
| 35.0% | |
| 21.4% | |
| 20.9% | |
| 17.2% | |
| 13.6% | |
| 5.8% | |
| 2.7% |
- 37.2%
- 35.0%
- 20.9%
- 17.2%
- 13.6%
- 5.8%
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation